# Clinical Investigation to Evaluate the Ability of MammoWave in Breast Lesions Detection

> **NCT04253366** · NA · COMPLETED · sponsor: **Umbria Bioengineering Technologies** · enrollment: 353 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DEVICE:** Clinical investigation device class IIa not marked CE

## Key facts

- **NCT ID:** NCT04253366
- **Lead sponsor:** Umbria Bioengineering Technologies
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-16
- **Primary completion:** 2021-08-20
- **Final completion:** 2021-08-20
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2021-08-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04253366

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04253366, "Clinical Investigation to Evaluate the Ability of MammoWave in Breast Lesions Detection". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT04253366. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*